---
title: "12 Health Care Stocks Moving In Friday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303746049.md"
description: "In Friday's pre-market session, several healthcare stocks showed significant movement. Gainers included NRX Pharmaceuticals (+12%), Intensity Therapeutics (+9.58%), and iSpecimen (+9.42%). Conversely, major losers were Acumen Pharmaceuticals (-77.5%) following Q3 earnings, Alphatec Holdings (-31.93%) after its Q3 report, and ProMIS Neurosciences (-24.1%). These fluctuations reflect investor reactions to recent financial disclosures and market sentiment."
datetime: "2026-10-30T12:05:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303746049.md)
  - [en](https://longbridge.com/en/news/303746049.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303746049.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Pre-Market Session

### Gainers

-   **NRX Pharmaceuticals** (NASDAQ:NRXP) shares increased by 12.0% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $115.1 million.
-   **Intensity Therapeutics** (NASDAQ:INTS) stock rose 9.58% to $3.66. The company's market cap stands at $10.9 million.
-   **iSpecimen** (NASDAQ:ISPC) shares moved upwards by 9.42% to $0.87. The company's market cap stands at $1.9 million.
-   **Entera Bio** (NASDAQ:ENTX) shares moved upwards by 9.29% to $3.41. The company's market cap stands at $542.6 million.
-   **Clearmind Medicine** (NASDAQ:CMND) stock rose 8.54% to $6.35. The company's market cap stands at $2.9 million.
-   **Psyence Biomedical** (NASDAQ:PBM) stock increased by 8.5% to $3.92. The company's market cap stands at $13.7 million.

### Losers

-   **Acumen Pharmaceuticals** (NASDAQ:ABOS) shares decreased by 77.5% to $0.51 during Friday's pre-market session. The company's market cap stands at $165.6 million. As per the press release, Q3 earnings came out 4 days ago.
-   **Alphatec Holdings** (NASDAQ:ATEC) stock fell 31.93% to $7.74. The market value of their outstanding shares is at $1.7 billion. As per the news, the Q3 earnings report came out yesterday.
-   **ProMIS Neurosciences** (NASDAQ:PMN) shares fell 24.1% to $8.41. The company's market cap stands at $99.3 million.
-   **Senti Biosciences** (NASDAQ:SNTI) shares decreased by 18.35% to $0.18. The company's market cap stands at $8.3 million.
-   **OmniAb** (NASDAQ:OABI) stock fell 16.07% to $4.39. The company's market cap stands at $758.2 million. As per the press release, Q3 earnings came out today.
-   **Davion Healthcare** (NASDAQ:DAVI) shares declined by 14.13% to $2.31. The company's market cap stands at $67.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ABOS.US](https://longbridge.com/en/quote/ABOS.US.md)
- [ATEC.US](https://longbridge.com/en/quote/ATEC.US.md)
- [CMND.US](https://longbridge.com/en/quote/CMND.US.md)
- [ENTX.US](https://longbridge.com/en/quote/ENTX.US.md)
- [INTS.US](https://longbridge.com/en/quote/INTS.US.md)
- [ISPC.US](https://longbridge.com/en/quote/ISPC.US.md)
- [NRXP.US](https://longbridge.com/en/quote/NRXP.US.md)
- [OABI.US](https://longbridge.com/en/quote/OABI.US.md)
- [PBM.US](https://longbridge.com/en/quote/PBM.US.md)
- [SNTI.US](https://longbridge.com/en/quote/SNTI.US.md)

## Related News & Research

- [iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent | ISPC Stock News](https://longbridge.com/en/news/303622752.md)
- [OmniAb Q3 revenue beats on antibody, ion channel programs growth](https://longbridge.com/en/news/303742432.md)
- [ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law](https://longbridge.com/en/news/304207374.md)
- [Alphatec Holdings Director David M. Demski Reports Acquisition of $408,600 in Common Shares](https://longbridge.com/en/news/303993667.md)
- [NRX Pharmaceuticals Grants CEO Jonathan Javitt 150,000 Restricted Stock Units](https://longbridge.com/en/news/304353479.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**